Mesalamine Controlled-Release Capsules and Ribociclib and Letrozole
Determining the interaction of Mesalamine Controlled-Release Capsules and Ribociclib and Letrozole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Letrozole and ribociclib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Ribociclib Succinate
- Mesalamine Controlled-Release Capsules-Rid-A-Pain Topical
- Mesalamine Controlled-Release Capsules-Ridactate
- Mesalamine Controlled-Release Capsules-Ridaura
- Mesalamine Controlled-Release Capsules-Rifabutin
- Mesalamine Controlled-Release Capsules-Rifadin
- Ribociclib and Letrozole-Mesalamine Delayed Release Tablets
- Ribociclib and Letrozole-Mesalamine Long-Acting Capsules (Apriso)
- Ribociclib and Letrozole-Mesalamine Long-Acting Capsules (Delzicol)
- Ribociclib and Letrozole-Mesalamine Long-Acting Capsules (Pentasa)
- Ribociclib and Letrozole-Mesalamine rectal
- Ribociclib and Letrozole-Mesalamine Rectal Enema